Evidence map›Paper›PMID 17403873›Full record

ArticleInfection and immunity2007

Interleukin-23 (IL-23)-IL-17 cytokine axis in murine Pneumocystis carinii infection.

Xiaowen L Rudner, Kyle I Happel, Erana A Young, Judd E Shellito

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 134 papers.

0numbers the graph read from it
0cells of the map it votes in
134citing papers in PubMed
13.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

134 citing papers in PubMed, 245 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Immune responses of different hosts toEuropean respiratory review : an official journal of the European Respiratory Society · 2025
    Review
  6. T-cell subsets inClinical & translational immunology · 2025
    Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. T cells in health and disease.Signal transduction and targeted therapy · 2023
    Review
  13. Th17/Treg Imbalance: Implications in Lung Inflammatory Diseases.International journal of molecular sciences · 2023
    Review
  14. Article
  15. Article
  16. Article
  17. Bias of the Immune Response toJournal of fungi (Basel, Switzerland) · 2021
    Article
  18. Immune Response inJournal of fungi (Basel, Switzerland) · 2021
    Review
  19. Article
  20. Review

74 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Xiaowen L RudnerSection of Pulmonary and Critical Care Medicine, Department of Medicine, Louisiana State University, LSU Health Sciences Center, 1901 Perdido Street, New Orleans, LA 70112, USA.
Kyle I Happel
Erana A Young
Judd E Shellito
Louisiana State University Health Sciences Center New Orleans · US

Funding

Vaccine strategies against pneumocystis in non-human primatesP01HL076100 · NHLBI · LSU HEALTH SCIENCES CENTER · PI NORRIS, KAREN A · 2004 to 2015
$17.7M
TUMOR MICROENVIRONMENT AND B CELL LYMPHOMASP20RR021970 · NCRR · LSU HEALTH SCIENCES CENTER · PI ESTRADA, JOHN J. · 2005 to 2011
$14.1M
IL-17 and Klebsiella PneumoniaR01AI051677 · NIAID · LSU HEALTH SCIENCES CENTER · PI SHELLITO, JUDD E · 2002 to 2007
$2.0M
Alcohol, Pulmonary Cytokines, and Host DefenseK08AA015163 · NIAAA · LSU HEALTH SCIENCES CENTER · PI HAPPEL, KYLE I · 2004 to 2009
$1.0M
NCRR NIH HHS 1P20 RR 021970-01NCRR NIH HHS P20 RR021970NHLBI NIH HHS P01 HL 076100NHLBI NIH HHS P01 HL076100NIAAA NIH HHS K08 AA 015163NIAAA NIH HHS K08 AA015163NIAID NIH HHS R01 AI051677NIAID NIH HHS R01 AI 51677
6 · The paper itself

Abstract

Host defense mechanisms against Pneumocystis carinii are not fully understood. Previous work in the murine model has shown that host defense against infection is critically dependent upon host CD4(+) T cells. The recently described Th17 immune response is predominantly a function of effector CD4(+) T cells stimulated by interleukin-23 (IL-23), but whether these cells are required for defense against P. carinii infection is unknown. We tested the hypothesis that P. carinii stimulates the early release of IL-23, leading to increases in IL-17 production and lung effector CD4(+) T-cell population that mediate clearance of infection. In vitro, stimulation of alveolar macrophages with P. carinii induced IL-23, and IL-23p19 mRNA was expressed in lungs of mice infected with this pathogen. To address the role of IL-23 in resistance to P. carinii, IL-23p19-/- and wild-type control C57BL/6 mice were infected and their fungal burdens and cytokine/chemokine responses were compared. IL-23p19-/- mice displayed transient but impaired clearance of infection, which was most apparent 2 weeks after inoculation. In confirmatory studies, the administration of either anti-IL-23p19 or anti-IL-17 neutralizing antibody to wild-type mice infected with P. carinii also caused increases in fungal burdens. IL-17 and the lymphocyte chemokines IP-10, MIG, MIP-1alpha, MIP-1beta, and RANTES were decreased in the lungs of infected IL-23p19-/- mice in comparison to their levels in the lungs of wild-type mice. In IL-23p19-/- mice infected with P. carinii, there were fewer effector CD4(+) T cells in the lung tissue. Collectively, these studies indicate that the IL-23-IL-17 axis participates in host defense against P. carinii.

Indexed as

AnimalsCytokinesHost-Parasite InteractionsInterleukin-17Interleukin-23LungMiceMice, Inbred BALB CMice, Inbred C57BLPneumocystisPneumonia, PneumocystisCytokinesInterleukin-17Interleukin-23

Identifiers

PMID17403873
PMCPMC1932856
OpenAlexW2121576483

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.